COMPANY
Surface Ophthalmics
Timeline
- Trial start Phase 2: A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease source ↗
- Trial start Phase 2: Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease source ↗
- Trial start Phase 2: Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects source ↗
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT04734210 | Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease | Phase 2 | Completed | Jan 7, 2021 | Oct 12, 2022 (actual) |
| NCT04734197 | A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease | Phase 2 | Completed | Jan 11, 2021 | Mar 25, 2022 (actual) |
| NCT04324359 | Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects | Phase 2 | Completed | Mar 3, 2020 | Nov 3, 2020 (actual) |